Results 261 to 270 of about 2,681,651 (342)

Advances in Photonic Materials and Integrated Devices for Smart and Digital Healthcare: Bridging the Gap Between Materials and Systems

Advanced Materials, EarlyView.
This article summarizes significant technological advancements in materials, photonic devices, and bio‐interfaced systems, which demonstrate successful applications for impacting human healthcare via improved therapies, advanced diagnostics, and on‐skin health monitoring.
Seunghyeb Ban, Hoon Yi, Jaejin Park, Yunuo Huang, Ki Jun Yu, Woon‐Hong Yeo   +5 more
wiley   +1 more source

Competitive adsorption of a monoclonal antibody and amphiphilic polymers to the air-water interface. [PDF]

Eur Biophys J
Hingst EJ, Blech M, Hinderberger D, Garidel P, Schwieger C.   +4 more
europepmc   +1 more source

Phenotypes in chronic B-lymphocytic leukemia probed by monoclonal antibodies and immunoglobulin secretion studies: identification of stages of maturation arrest and the relation to clinical findings [PDF]

, 1983
J Gordon, H Mellstedt, Pierre Åman, P Biberfeld, M Bjorkholm, George Klein   +5 more
openalex   +1 more source

Bi‐Functional Topospecific Nanoparticles to Promote Immune‐Tumor Cell Engagement as A New Immunotherapeutic Strategy

Advanced Materials, EarlyView.
A Janus‐engineered nanoplatform (J‐pHLIP‐PD1), featuring separate tumor‐ and immune‐targeting faces, bridges melanoma cells and cytotoxic T lymphocytes using toposelective pHLIP and anti‐PD‐1 presentation. This strategy elicits robust antitumor responses, promotes immunogenic tumor cell death, suppresses lung metastasis in vivo, and provides a modular,
Alba Ortuño‐Bernal, Sandra Clara‐Trujillo, Elena Lucena‐Sánchez, Francisco J. Hicke, Andrea Escudero, Sandra Pradana‐López, Nelia Jiménez‐Alduan, Paula Díez, Alba García‐Fernández, Ramón Martínez‐Máñez   +9 more
wiley   +1 more source

Effectiveness and Safety of Outpatient Monoclonal Antibody Use for the Treatment of COVID-19 in Children and Adolescents: Single Center Study. [PDF]

J Pediatr Pharmacol Ther
Cheng J, Heideman E, Espinosa C, Zeitler K, Piccicacco N, Gaviria-Agudelo C.   +5 more
europepmc   +1 more source

Analyses of HLA antigens, especially HLA-A and -B interlocus antigen, on platelets with monoclonal antibodies and elisa assay.

, 1987
Yoshisuke Nose, Nobuo Araki, Hiroji Yamahira, Junya Shimizu, Kaoru Sato, Takako Nakatsuji, Kimiyoshi Tsuji, Kazuo Ōno   +7 more
openalex   +2 more sources

Structural studies on induced antibodies with defined idiotypic specificities. IX. Framework differences in the heavy- and light-chain-variable regions of monoclonal anti-p-azophenylarsonate antibodies from A/J mice differing with respect to a cross-reactive idiotype. [PDF]

, 1980
Pila Estess, Edmundo Lamoyi, Alfred Nisonoff, J D Capra   +3 more
openalex   +1 more source

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

Science, 1989
B. Trauth, C. Klas, A. Peters, S. Matzku, Peter Möller, W. Falk, K. Debatin, P. Krammer   +7 more
semanticscholar   +1 more source

An Ultrapotent, Ultraeconomical, Antifreeze Polypeptide

Advanced Materials, EarlyView.
Simple and inexpensive polypeptides composed of random copolymers of alanine and glutamic acid are effective antifreezes for applications in foods and biomedicine. The polypeptides, inspired by natural extremophile proteins, inhibit the growth of large ice crystals and prevent damage to sensitive biologics.
Thomas J. McPartlon, Charles T. Osborne, Ke Wang, Rachel E. Detwiler, Konrad Meister, Jessica R. Kramer   +5 more
wiley   +1 more source

Cancer therapy via neoepitope-specific monoclonal antibody cocktails. [PDF]

Cancer Immunol Immunother
Hartman CJ, Mohamed AO, Shukla GS, Pero SC, Sun YJ, Rodríguez-Jimenez RS, Genovese NF, Kohler NM, Hemphill TR, Huang YH, Krag DN, Ackerman ME.   +11 more
europepmc   +1 more source